To test if the LMP1-IKK2-TPL2-JNK pathway is also effective in PTLD, primary tumor cells were established in culture from tumor biopsies of two PTLD patients, resulting in PTLD099 and PTLD880 cells. This evidence concerns the gene MAPK8 and post-transplant lymphoproliferative disease.